The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
Abstract
Background There has been tremendous growth in research in pediatric multiple sclerosis (MS) and immune mediated central nervous system demyelinating disorders since operational definitions for these conditions were first proposed in 2007. Further, the International Pediatric Multiple Sclerosis Study Group (IPMSSG), which proposed the criteria, has expanded substantially in membership and in its international scope. Objective The purpose of this review is to revise the 2007 definitions in order to incorporate advances in delineating the clinical and neuroradiologic features of these disorders. Methods Through a consensus process, in which input was sought from the 150 members of the Study Group, criteria were drafted, revised and finalized. Final approval was sought through a web survey. Results Revised criteria are proposed for pediatric acute disseminated encephalomyelitis, pediatric clinically isolated syndrome, pediatric neuromyelitis optica and pediatric MS. These criteria were approved by 93% or more of the 56 Study Group members who responded to the final survey. Conclusions These definitions are proposed for clinical and research purposes. Their utility will depend on the outcomes of their application in prospective research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although MS typically presents at age 20-50 years, approximately 0.5% of adults with MS have symptom onset at age 60 years or older. 42,43”
From Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018) · cites this paper as [43]
In the citing paper
“In younger children (<12 years) MS may present differently from adolescents and adults; encephalopathy, multifocal neurological deficits (often with prominent brainstem/cerebellar involvement) and seizures are more common.32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“Up to 5% of people with MS develop their first symptoms in childhood, almost always RRMS. 32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“The performance of the McDonald 2010 criteria has been tested in children with CIS and the criteria have a similar sensitivity/specificity for the development of MS as in adult populations 35 but should not be applied in the setting of encephalopathy (i.e.ADEM).32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“ADEM is almost always monophasic; however, an encephalopathic ADEM-like illness can sometimes be the first presentation of MS in both children 32,34 and adults 43 and diagnostic criteria for ADEM remain imperfect.”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“The clinical, imaging and laboratory features of ADEM and MS overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural or cognitive change) in making the diagnosis of ADEM (Supplementary Panel 1).32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“Older children (≥12 years) usually present with clinical features and MRI findings similar to adults with CIS.32,34”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Self-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251
Fisniku, L. K., Brex, P. A., Altmann, D. R., Miszkiel, K. A., Benton, C. E., Lanyon, R., Thompson, A. J., & Miller, D. H. (2008) · Brain · doi:10.1093/brain/awm329 · Cited by 897
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
Krupp, L., Banwell, B., & Tenembaum, S. N. (2007) · Neurology · doi:10.1212/01.wnl.0000259422.44235.a8 · Cited by 757
Self-citationAcute disseminated encephalomyelitis
Tenembaum, S. N., Chamoles, N., & Fejerman, N. (2002) · Neurology · doi:10.1212/wnl.59.8.1224 · Cited by 708
Self-citationIncreased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
Gorman, M., Healy, B. C., Polgar‐Turcsanyi, M., & Chitnis, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.505 · Cited by 459
Self-citationEarly onset multiple sclerosis
Бойко, А. Н., Vorobeychik, G., Paty, D. W., Devonshire, V., & Sadovnick, A. D. (2002) · Neurology · doi:10.1212/wnl.59.7.1006 · Cited by 417
Acute Disseminated Encephalomyelitis in Childhood: Epidemiologic, Clinical and Laboratory Features
Leake, J. A. D., Albani, S., Kao, A. S., Senac, M. O., Billman, G. F., Nespeca, M., Paulino, A., Quintela, E. R., Sawyer, M. H., & Bradley, J. S. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133048.75452.dd · Cited by 411
Course and prognosis in early-onset MS
Simone, I. L., Carrara, D., Tortorella, C., Liguori, M., Lepore, V. L., Pellegrini, F., Bellacosa, A., Ceccarelli, A., Pavone, I., & Livrea, P. (2002) · Neurology · doi:10.1212/01.wnl.0000036907.37650.8e · Cited by 341
Cited by
Sorted by citations
Items 101–200 of 1,000
Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids
Matsumoto, Y., Kaneko, K., Takahashi, T., Takai, Y., Namatame, C., Kuroda, H., Misu, T., Fujihara, K., & Aoki, M. (2023) · Brain · doi:10.1093/brain/awad122 · Cited by 72
de Mol, C. L., Wong, Y. Y. M., van Pelt, E. D., Ketelslegers, I. A., Bakker, D. P., Boon, M., Braun, K. P. J., van Dijk, K. G. J., Eikelenboom, M. J., Engelen, M., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8835-6 · Cited by 71
Self-citationRamanathan, S., O’Grady, G. L., Malone, S., Spooner, C. G., Brown, D. A., Gill, D. S., Brilot, F., & Dale, R. C. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14032 · Cited by 71
Self-citationNeuroimaging in encephalitis: analysis of imaging findings and interobserver agreement
Granerød, J., Davies, N. W. S., Mukonoweshuro, W., Mehta, A., Das, K., Lim, M. J., Solomon, T., Biswas, S., Rosella, L. C., Brown, D., et al. (2016) · Clinical Radiology · doi:10.1016/j.crad.2016.03.015 · Cited by 70
Clinical characteristics of Epstein–Barr virus infection in the pediatric nervous system
Cheng, H., Chen, D.-D., Peng, X., Wu, P., Jiang, L., & Hu, Y. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05623-1 · Cited by 70
Rituximab Use in Pediatric Central Demyelinating Disease
Beres, S., Graves, J., & Waubant, E. L. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.02.007 · Cited by 69
Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis
Graves, J., Chitnis, T., Weinstock‐Guttman, B., Rubin, J. P., Zelikovitch, A., Nourbakhsh, B., Simmons, T. C., Waltz, M., Casper, T. C., & Waubant, E. L. (2017) · PEDIATRICS · doi:10.1542/peds.2016-2838 · Cited by 71
Self-citationde Oliveira, M. C. B., de Brito, M. H., & Simabukuro, M. M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.538695 · Cited by 76
Presentations and mechanisms of CNS disorders related to COVID-19
Bodro, M., Compta, Y., & Sánchez‐Valle, R. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000923 · Cited by 69
Clinical and neuroimaging findings in MOGAD–MRI and OCT
Bartels, F., Lu, A., Oertel, F. C., Finke, C., Paul, F., & Chien, C. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13641 · Cited by 68
Foiadelli, T., Gastaldi, M., Scaranzin, S., Franciotta, D. M., & Savasta, S. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102011 · Cited by 66
Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
Wendel, E. M., Thonke, H. S., Bertolini, A., Baumann, M., Blaschek, A., Merkenschlager, A., Karenfort, M., Kornek, B., Lechner, C., Pohl, D., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200035 · Cited by 65
Self-citationAcute idiopathic transverse myelitis in children
Deiva, K., Absoud, M., Hemingway, C. A., Hernandez, Y., Hussson, B., Maurey, H., Niotakis, G., Wassmer, E., Lim, M. J., Tardieu, M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001179 · Cited by 66
Self-citationYamout, B., Aljumah, M., Sahraian, M. A., Almalik, Y., Khaburi, J. A., Shalaby, N., Aljarallah, S., Bohlega, S., Dahdaleh, M., Almahdawi, A., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105435 · Cited by 81
Neuroimmune disorders of the central nervous system in children in the molecular era
Wells, E. M., Hacohen, Y., Waldman, A. T., Tillema, J. M., Soldatos, A. G., Ances, B. M., Benseler, S. M., Bielekova, B., Dale, R. C., Dalmau, J. O., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0024-9 · Cited by 67
Self-citationRossor, T. E., Benetou, C., Wright, S. K., Duignan, S. M., Lascelles, K., Robinson, R. A., Das, K., Ciccarelli, O., Wassmer, E., Hemingway, C. A., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458518823486 · Cited by 64
Self-citationSilent New Brain MRI Lesions in Children with MOG‐Antibody Associated Disease
Fadda, G., Banwell, B., Waters, P. J., Marrie, R. A., Yeh, E. A., O’Mahony, J., Arnold, D. L., Bar‐Or, A., & the Canadian Pediatric Demyelinating Disease Network (2020) · Annals of Neurology · doi:10.1002/ana.25957 · Cited by 62
Self-citationMRI mimics of multiple sclerosis
Aliaga, E. S., & Barkhof, F. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00012-1 · Cited by 65
Menarche increases relapse risk in pediatric multiple sclerosis
Lulu, S., Graves, J., & Waubant, E. L. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515581873 · Cited by 63
Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 – continuity and change
Hartung, H., Graf, J., Aktaş, O., Mareš, J., & Barnett, M. H. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000699 · Cited by 64
Brainstem encephalitis: etiologies, treatment, and predictors of outcome
Tan, I. L., Mowry, E. M., Steele, S. U., Pardo, C. A., McArthur, J. C., Nath, A., & Venkatesan, A. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6986-z · Cited by 62
Genetic risk factors for pediatric-onset multiple sclerosis
Gianfrancesco, M. A., Stridh, P., Shao, X., Rhead, B. L., Graves, J. S., Chitnis, T., Waldman, A. T., Lotze, T. E., Schreiner, T., Belman, A. L., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517733551 · Cited by 62
Self-citationBaroncini, D., Zaffaroni, M., Moiola, L., Lorefice, L., Fenu, G., Iaffaldano, P., Simone, M., Fanelli, F., Patti, F., D’Amico, E., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518754364 · Cited by 62
Self-citationWong, Y. Y. M., Hacohen, Y., Armangué, T., Wassmer, E., Verhelst, H., Hemingway, C. A., van Pelt, E. D., Catsman‐Berrevoets, C. E., Hintzen, R. Q., Deiva, K., et al. (2018) · European Journal of Neurology · doi:10.1111/ene.13602 · Cited by 62
Self-citationPauli, F. D., & Berger, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02753 · Cited by 62
Yan, J., Kothur, K., Mohammad, S. S., Chung, J., Patel, S., Jones, H. F., Keating, B. A., Han, V. X., Webster, R., Ardern‐Holmes, S. L., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104589 · Cited by 61
Self-citationDiagnosis and therapy of acute disseminated encephalomyelitis and its variants
Berzero, G., Cortese, A., Ravaglia, S., & Marchioni, E. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1126510 · Cited by 61
Alroughani, R., Das, R., Penner, N., Pultz, J., Taylor, C., & Eraly, S. A. (2018) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2018.03.007 · Cited by 61
Real-world validation of the 2017 McDonald criteria for pediatric MS
Wong, Y. Y. M., de Mol, C. L., de Vries, R. M. V. D. V., van Pelt, E. D., Ketelslegers, I. A., Catsman‐Berrevoets, C. E., Neuteboom, R. F., & Hintzen, R. Q. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000528 · Cited by 64
Self-citationEpidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy
Dell’Avvento, S., Sotgiu, M. A., Manca, S., Sotgiu, G., & Sotgiu, S. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2588-3 · Cited by 61
Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient
Wang, C. X. (2021) · Pediatric Drugs · doi:10.1007/s40272-021-00441-7 · Cited by 73
Brenton, J. N., & Banwell, B. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0396-0 · Cited by 59
Self-citationSocial cognition in pediatric-onset multiple sclerosis (MS)
Charvet, L. E., Cleary, R., Vazquez, K., Belman, A. L., Krupp, L., & on behalf of the US Network for Pediatric MS (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514526942 · Cited by 59
Self-citationSartori, S., Nosadini, M., Cesaroni, E., Falsaperla, R., Capovilla, G., Beccaria, F., Mancardi, M. M., Santangelo, G., Giunta, L., Boniver, C., et al. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2015.02.006 · Cited by 59
Suppiej, A., Cainelli, E., Casara, G., Cappellari, A., Nosadini, M., & Sartori, S. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.12.006 · Cited by 59
Boesen, M. S., Magyari, M., Koch‐Henriksen, N., Thygesen, L. C., Born, A. P., Uldall, P. V., & Blinkenberg, M. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517713669 · Cited by 59
Ho, A. C. C., Mohammad, S. S., Pillai, S. C., Tantsis, E. M., Jones, H. F., Ho, R., Lim, M. J., Hacohen, Y., Vincent, A. C., & Dale, R. C. (2017) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13579 · Cited by 60
Self-citationWhite matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders
Longoni, G., Brown, R. A., MomayyezSiahkal, P., Elliott, C., Narayanan, S., Bar‐Or, A., Marrie, R. A., Yeh, E. A., Filippi, M., Banwell, B., et al. (2017) · Brain · doi:10.1093/brain/awx041 · Cited by 59
Self-citationEffect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis
Vermersch, P., Scaramozza, M., Levin, S. N., Alroughani, R., Deiva, K., Pozzilli, C., Lyons, J. L., Mokliatchouk, O., Pultz, J., N’Dure, F., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.30439 · Cited by 57
Chen, L., Chen, C., Zhong, X., Sun, X., Zhu, H., Li, X., Yang, H., Shu, Y., Chang, Y., Hu, X., et al. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.05.014 · Cited by 58
Horellou, P., Wang, M., Keo, V., Chrétien, P., Serguera, C., Waters, P. J., & Deiva, K. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.10.002 · Cited by 56
Bigi, S., Banwell, B., & Yeh, E. A. (2014) · Journal of Child Neurology · doi:10.1177/0883073814545883 · Cited by 56
Self-citationBartels, F., Nobis, K., Cooper, G. A., Wendel, E. M., Cleaveland, R., Bajer-Kornek, B., Blaschek, A., Schimmel, M., Blankenburg, M. R., Baumann, M., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519829698 · Cited by 56
Self-citationPediatric acquired CNS demyelinating syndromes
Hintzen, R. Q., Dale, R. C., Neuteboom, R. F., Mar, S., & Banwell, B. (2016) · Neurology · doi:10.1212/wnl.0000000000002881 · Cited by 55
Self-citationChoi, J., Kim, S. Y., Kim, H., Lim, B. C., Hwang, H. Y., Chae, J., Kim, K. J., Oh, S., Kim, E. Y., & Shin, J. (2020) · BMC Neurology · doi:10.1186/s12883-020-01662-y · Cited by 55
Zhou, J., Lu, X., Zhang, Y., Ji, T., Jin, Y., Xu, M., Bao, X., Zhang, Y., Xiong, H., Chang, X., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.12.001 · Cited by 54
Pediatric versus adult MS: similar or different?
Ghezzi, A., Baroncini, D., Zaffaroni, M., & Comi, G. (2017) · Multiple Sclerosis and Demyelinating Disorders · doi:10.1186/s40893-017-0022-6 · Cited by 53
Self-citationMOG-IgG1 and co-existence of neuronal autoantibodies
Kunchok, A. C., Flanagan, E. P., Krecke, K. N., Chen, J. J.-W., Caceres, J., Dominick, J., Ferguson, I., Kinkel, R. P., Probasco, J. C., Ruvalcaba, M., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520951046 · Cited by 53
Prognostic indicators in pediatric clinically isolated syndrome
Iaffaldano, P., Simone, M., Lucisano, G., Ghezzi, A., Coniglio, G., Morra, V. B., Salemi, G., Patti, F., Lugaresi, A., Izquierdo, G., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24938 · Cited by 52
Self-citationStephens, S., Shams, S., Lee, J., Grover, S. A., Longoni, G., Berenbaum, T. S., Finlayson, M. L., Motl, R. W., & Yeh, E. A. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.01.040 · Cited by 51
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex
Margoni, M., Gueye, M., Meani, A., Pagani, E., Moiola, L., Preziosa, P., Filippi, M., & Rocca, M. A. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330343 · Cited by 50
MRI in the evaluation of pediatric multiple sclerosis
Banwell, B., Arnold, D. L., Tillema, J., Rocca, M. A., Filippi, M., Weinstock‐Guttman, B., Zivadinov, R., & Sormani, M. P. (2016) · Neurology · doi:10.1212/wnl.0000000000002787 · Cited by 50
Self-citationHacohen, Y., Brownlee, W. J., Mankad, K., Chong, W. K., Thompson, A. J., Lim, M. J., Wassmer, E., Hemingway, C. A., Barkhof, F., & Ciccarelli, O. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519863781 · Cited by 51
Self-citationde Vries, R. M. V. D. V., Wong, Y. Y. M., Mescheriakova, J. Y., van Pelt, E. D., Runia, T. F., Jafari, N., Siepman, T. A. M., Melief, M., Wierenga‐Wolf, A. F., van Luijn, M. M., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518775303 · Cited by 49
Self-citationPrognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination
Savransky, A., Rubstein, A., Huaman, M., Vergel, S., Velasquez, M. C., Sierra, S. P., Marcarian, G., Alba, R., Pugliese, A., & Tenembaum, S. N. (2019) · Neurology · doi:10.1212/wnl.0000000000008551 · Cited by 49
Self-citationClinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children
Hou, C., Wu, W., Tian, Y., Zhang, Y., Zhu, H., Zeng, Y., Peng, B., Zheng, K., Li, X., & Chen, W. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102018 · Cited by 50
Potential Role of CHI3L1+ Astrocytes in Progression in MS
Cubas-Núñez, L., Gil‐Perotín, S., Castillo-Villalba, J., López, V. P., Tarazona, L. R. S., Gasqué-Rubio, R., Carratalà‐Boscà, S., Alcalà-Vicente, C., Miralles, F. C. P., Lassmann, H., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000972 · Cited by 58
Capasso, N., Virgilio, E., Covelli, A., Giovannini, B., Foschi, M., Montini, F., Nasello, M., Nilo, A., Prestipino, E., Schirò, G., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1207617 · Cited by 52
Simone, M., Viterbo, R. G., Margari, L., & Iaffaldano, P. (2018) · BMC Neurology · doi:10.1186/s12883-018-1087-3 · Cited by 52
Update on Acute Disseminated Encephalomyelitis in Children and Adolescents
Massa, S., Fracchiolla, A., Neglia, C., Argentiero, A., & Esposito, S. (2021) · Children · doi:10.3390/children8040280 · Cited by 48
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper
Halsey, N. A., Talaat, K. R., Greenbaum, A. H., Mensah, E., Dudley, M. Z., Proveaux, T. M., & Salmon, D. A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.080 · Cited by 50
Boesen, M. S., Blinkenberg, M., Koch‐Henriksen, N., Thygesen, L. C., Uldall, P. V., Magyari, M., & Born, A. P. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13798 · Cited by 46
Pediatric Multiple Sclerosis: an Update
Otallah, S., & Banwell, B. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0886-7 · Cited by 48
Self-citationFunctional–structural correlations in the afferent visual pathway in pediatric demyelination
Yeh, E. A., Marrie, R. A., Reginald, Y. A., Buncic, J. R., Noguera, A., O’Mahony, J., Mah, J. K., Banwell, B., & Costello, F. (2014) · Neurology · doi:10.1212/wnl.0000000000001046 · Cited by 45
Self-citationTreatment adherence and transitioning youth in pediatric multiple sclerosis
Lulu, S., Julian, L. J., Shapiro, E. M., Hudson, K., & Waubant, E. L. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.09.088 · Cited by 46
Recovery From Central Nervous System Acute Demyelination in Children
O’Mahony, J., Marrie, R. A., Laporte, A., Yeh, E. A., Bar‐Or, A., Phan, C., Buckley, D. J., Callen, D. J. A., Connolly, M. B., Pohl, D., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2015-0028 · Cited by 45
Self-citationCaffarelli, M., Kimia, A. A., & Torres, A. R. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.08.025 · Cited by 45
Bindu, P. S., Sonam, K., Chiplunkar, S., Govindaraj, P., Nagappa, M., Vekhande, C. C., Aravinda, H. R., Ponmalar, J. N. J., Mahadevan, A., Gayathri, N., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.01.003 · Cited by 45
Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis
Baruch, N. F., O’Donnell, E., Glanz, B. I., Benedict, R. H. B., Musallam, A., Healy, B. C., Rintell, D. J., & Chitnis, T. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515588781 · Cited by 45
Self-citationFingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger Than Age 18 Years
Fragoso, Y. D., Alves‐Leon, S. V., Barreira, A. A., Callegaro, D., Ferreira, M. L. B., Finkelsztejn, A., Gomes, S., Gonçalves, M. V. M., Machado, M. Í. D. M., Marques, V. D., et al. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.03.024 · Cited by 44
Hottenrott, T., Dersch, R. S., Berger, B., Rauer, S., Eckenweiler, M., Huzly, D., & Stich, O. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0024-8 · Cited by 45
Pediatric Optic Neuritis: What Is New
Borchert, M., Liu, G. T., Pineles, S. L., & Waldman, A. T. (2017) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000551 · Cited by 44
Mao, L., Yang, L., Kessi, M., He, F., Zhang, C., Wu, L., Yin, F., & Peng, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00868 · Cited by 43
Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
Correale, J. D., & Ysrraelit, M. C. (2022) · ASN NEURO · doi:10.1177/17590914221118502 · Cited by 45
Pediatric onset multiple sclerosis
Deiva, K. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.02.002 · Cited by 47
Boesen, M. S., Jensen, P. E., Born, A. P., Magyari, M., Nilsson, A. C., Hoei‐Hansen, C. E., Blinkenberg, M., & Sellebjerg, F. T. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.06.002 · Cited by 44
Otallah, S. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520929627 · Cited by 42
Pediatric Multiple Sclerosis: Current Concepts and Consensus Definitions
Peña, J. A., & Lotze, T. E. (2013) · Autoimmune Diseases · doi:10.1155/2013/673947 · Cited by 41
Physical Activity and Its Correlates in Youth with Multiple Sclerosis
Grover, S. A., Sawicki, C. P., Kinnett-Hopkins, D., Finlayson, M. L., Schneiderman, J. E., Banwell, B., Till, C., Motl, R. W., & Yeh, E. A. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.08.104 · Cited by 41
Self-citationEkmekçi, Ö. (2017) · Behavioural Neurology · doi:10.1155/2017/1463570 · Cited by 41
Pediatric Neuromyelitis Optica Spectrum Disorders
Gombolay, G. Y., & Chitnis, T. (2018) · Current Treatment Options in Neurology · doi:10.1007/s11940-018-0502-9 · Cited by 43
Self-citationDynamic gray matter volume changes in pediatric multiple sclerosis
Meo, E. D., Meani, A., Moiola, L., Ghezzi, A., Veggiotti, P., Filippi, M., & Rocca, M. A. (2019) · Neurology · doi:10.1212/wnl.0000000000007267 · Cited by 46
Self-citationPediatric Central Nervous System Demyelinating Diseases
Chitnis, T. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000730 · Cited by 43
Self-citationKonuşkan, B., Yıldırım, M., Göçmen, R., Okur, T. D., Polat, İ., Kılıç, H., Saltık, S., Öztürk, Z., Gücüyener, K., Altunbaşak, Ş., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.022 · Cited by 40
New-Onset Refractory Status Epilepticus in Children: Etiologies, Treatments, and Outcomes*
Husari, K. S., Labiner, K., Huang, R., & Said, R. R. (2019) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002108 · Cited by 40
Wallach, A. I., Waltz, M., Casper, T. C., Aaen, G. S., Belman, A. L., Benson, L., Chitnis, T., Gorman, M., Graves, J. S., Harris, Y., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519891984 · Cited by 40
Self-citationKopp, T. I., Blinkenberg, M., Petersen, T., Sørensen, P. S., & Magyari, M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.101956 · Cited by 40
Attack phenotypes and disease course in pediatric MOGAD
Santoro, J. D., Beukelman, T., Hemingway, C. A., Hokkanen, S. R. K., Tennigkeit, F., & Chitnis, T. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51759 · Cited by 39
Self-citationCognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis
Margoni, M., Pagani, E., Meani, A., Preziosa, P., Mistri, D., Gueye, M., Moiola, L., Filippi, M., & Rocca, M. A. (2024) · Annals of Neurology · doi:10.1002/ana.26911 · Cited by 40
Baghbanian, S. M., Asgari, N., Sahraian, M. A., & Moghadasi, A. N. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.02.028 · Cited by 42
A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis
Toledano, M., Weinshenker, B. G., & Solomon, A. J. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0576-7 · Cited by 42
Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis
Rocca, M. A., Morelli, M. E., Amato, M. P., Moiola, L., Ghezzi, A., Veggiotti, P., Capra, R., Pagani, E., Portaccio, E., Fiorino, A., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515598569 · Cited by 39
Self-citationProtective environmental factors for neuromyelitis optica
Graves, J. S., Grandhe, S., Weinfurtner, K. M., Krupp, L., Belman, A. L., Chitnis, T., Ness, J., Weinstock‐Guttman, B., Gorman, M., Patterson, M. C., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001001 · Cited by 38
Self-citationEvaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists
Mirbagheri, S., Sorte, D. E., Zamora, C. A., Mossa‐Basha, M., Newsome, S. D., & Izbudak, I. (2016) · Clinical Radiology · doi:10.1016/j.crad.2016.05.020 · Cited by 38
Incidence and prevalence of MS in children
Marrie, R. A., O’Mahony, J., Maxwell, C. J., Ling, V., Yeh, E. A., Arnold, D. L., Bar‐Or, A., Banwell, B., for the Canadian Pediatric Demyelinating Disease Network, Canadian Pediatric Demyelinating Disease Network, et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006395 · Cited by 42
Self-citationClinical time course of pediatric acute disseminated encephalomyelitis
Nishiyama, M., Nagase, H., Tomioka, K., Tanaka, T. J., Yamaguchi, H., Ishida, Y., Toyoshima, D., Fujita, K., Maruyama, A., Sasaki, K., et al. (2019) · Brain and Development · doi:10.1016/j.braindev.2019.02.011 · Cited by 38
Understanding Childhood Neuroimmune Diseases of the Central Nervous System
Matricardi, S., Farello, G., Savasta, S., & Verrotti, A. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00511 · Cited by 40
Nakamura, M., Ogawa, R., Fujimori, J., Uzawa, A., Sato, Y., Nagashima, K., Kuriyama, N., Kuwabara, S., & Nakashima, I. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231156736 · Cited by 37
Chen, B., Gómez‐Figueroa, E., Redenbaugh, V., Francis, A. G., Satukijchai, C., Wu, Y. T., Messina, S., Sá, M., Woodhall, M. R., Paul, F., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26731 · Cited by 37
Self-citationHino‐Fukuyo, N., Haginoya, K., Nakashima, I., Sato, D. K., Takahashi, T., Misu, T., Fujihara, K., Hirose, M., Kakisaka, Y., Uematsu, M., et al. (2015) · Brain and Development · doi:10.1016/j.braindev.2015.02.006 · Cited by 37
Metadata
- Authors
- Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., Rostasy, K., Tenembaum, S., Wassmer, E., & for the International Pediatric Multiple Sclerosis Study Group
- Affiliations
- Stony Brook University Hospital (US)
- Hôpitaux universitaires Paris Sud (FR)
- University of Florence (IT)
- Children's Hospital of Philadelphia (US)
- Massachusetts General Hospital (US)
- The University of Sydney (AU)
- Centro Studi Sclerosi Multipl, Ospedale di Gallarate, Italy
- Erasmus MC (NL)
- Royal Children's Hospital (AU)
- Children's Hospital of Eastern Ontario (CA)
- Innsbruck Medical University (AT)
- Garrahan Hospital (AR)
- Birmingham Children's Hospital (GB)
- Corresponding author
- Krupp, Lauren B
- Tardieu, Marc
- ORCID
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2013-04-09
- Volume
- 19
- Issue
- 10
- Pages
- 1261-1267
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2025358672
- Cited by
- 1,130
- References
- 37
- Citations by year
- 2026: 57 · 2025: 74 · 2024: 95 · 2023: 111 · 2022: 102 · 2021: 106 · 2020: 99 · 2019: 100 · 2018: 98 · 2017: 93 · 2016: 80 · 2015: 60 · 2014: 42 · 2013: 10
- FWCI
- 47.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- pediatric multiple sclerosis, diagnostic criteria, acute disseminated encephalomyelitis, neuromyelitis optica, clinical features, consensus definition
- MeSH terms
- Child, Encephalomyelitis, Acute Disseminated, Humans, Multiple Sclerosis, Neuromyelitis Optica, Pediatrics, Demyelinating Autoimmune Diseases, CNS
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
